Event: Clinical Trial Magnifier Conference 2009 – Hong Kong

Dates: November 13 to 15, 2009

Organizer: Clinical Trials Centre, The University of Hong Kong

Venue: Li Ka Shing Faculty of Medicine Building, 21 Sassoon Road, The University of Hong Kong, Hong Kong SAR, China

Weblink：www.CTMConference.com or
Contact：Ms. Grace Wu

Email：ctmconference@e21mm.com

Tel：(852) 2186 8725

The Clinical Trial Magnifier Conference is being convened in Hong Kong on November 13-15, 2009.

It is a multidisciplinary forum for clinical research professionals, specifically addressing the issues and challenges you face daily in your professional life. In line with our mission to encourage continuous improvement of professional practices, the Conference will be making critical information available to participating professionals.

It is uniquely distinguishable as a neutral, global forum – completely independent from the influence of any organization or authority. Over 65 clinical research professionals have volunteered to deliver a speech at this conference. They come from 28 countries and representing both academia and industry.

12 years of ICH

The International Conference on Harmonisation’s Good Clinical Practice (ICH GCP) Guideline regulating clinical trial conduct of new medicines was adopted by drug regulatory authorities in the US, EC and Japan in 1996. Its impact has been significant in terms of globalization of sponsored clinical trials.

There are many aspects of sponsored clinical trials that are not specifically addressed in the ICH GCP Guideline – yet are still critical for smooth interaction between sponsor and investigator. Most of those issues are global in nature and some can be standardized. The focus of the Clinical Trial Magnifier Conference is to be a forum for Globalization and Standardization.

It will address the most pressing current issues, including:

- What contract terms are critical in a clinical trial agreement?

- What site duties can be delegated?

- What items can be charged for in a trial budget?

- What are the necessary qualities to become a wonderful investigator?

- What are the incentives for an investigator to participate in a sponsored clinical trial?

Clinical Research Professionals

Discovering and developing new medicinal products is an extremely complex process. It can take decades and involve professionals in virtually all working areas – from business, law, management and media to engineering, basic sciences, laboratory sciences, pharmacology and medicine.

A discovery made in a single research laboratory extends to sophisticated, specialist pre-clinical testing research laboratories before entering large-scale clinical trials involving thousands of patients, conducted by hundreds of clinical investigators in dozens of countries.

The drug development process is essentially a tremendous, multi-team marathon relay race, as one group of professionals hands over responsibility to the next.

Conference Focus and Attendances

The Magnifier Conference will focus on streamlining the sponsor-investigator interaction, by addressing the most central aspects.

It will address the latest legal, regulatory, financial, contractual, operational, ethical and quality assurance aspects of clinical trials – and most specifically, the interaction between sponsors and investigators, and trial conduct.

As such, the Magnifier Conference will be of critical interest to both clinical research novices or veterans....indeed, any professionals working anywhere in the world with study sponsors, research sites, or CROs.

For more details, please visit www.CTMConference.com or contact with Conference Secretariat - Ms. Grace Wu at ctmconference@e21mm.com or (852) 2186 8725.

Click here to download the brochure: (http://www.ctmconference.com/Download/CTMConference2009_leaflet.pdf)

Click here to download the tentative programme
(http://www.ctmconference.com/Download/CTMConference2009_tentativeprog.pdf)